Be part of the knowledge - Global Oncology Academy

Medical News

newswise.com
12/01/2020
Medical News
Mechanism of Action of Chloroquine/Hydroxychloroquine for COVID-19 Infection
Read more
sciencedaily.com
12/01/2020
Medical News
Wuhan Mass Screening Identifies Hundreds of Asymptomatic Cases
Read more
news-medical.net
12/01/2020
Medical News
Direct Oral Anticoagulant Does Not Appear to Offer Protection Against Severe ...
Read more
anu.edu.au
12/01/2020
Medical News
Cancer Shifts to Chronic Disease, So Living Well Matters
Read more

Popular

- Marianne J. Davies, DNP, ACNP, AOCNP
  Peer
- Julie R. Brahmer, MD, MSc
  Peer
1
CME/CE
0.25 credits
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhib...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
1
CME/CE
0.25 credits
El panorama cambiante del tratamiento del cáncer colorrectal metastásico con ...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
2
CME/CE
0.25 credits
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Co...
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
12
CME/CE
0.25 credits
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Mark A. Socinski, MD
  Peer
- Alexander Drilon, MD
  Peer
8
CME/CE
0.25 credits
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
- Mark A. Socinski, MD
  Peer
- Helena Yu, MD
  Peer
7
CME/CE
0.25 credits
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits
- John Healey, MD
  Peer
- William D. Tap, MD
  Peer
3
CME/CE
0.25 credits
A Multidisciplinary Approach to Treatment of Tenosynovial Giant Cell Tumor (T...
0.25 credits
- William J. Gradishar MD, FASCO, FACP
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
6
CME/CE
0.25 credits
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Met...
0.25 credits

Featured

- Mark A. Socinski, MD
  Peer
- Tarek M. Mekhail, MD, MSC, FRCSI, FRCSEd
  Peer
12
CME/CE
0.25 credits
Insights from the Latest Clinical Trials in Lung Cancer
0.25 credits
- William Mencia, MD, FACEHP, CHCP
  Peer
- Roy F. Chemaly, MD, MPH, FIDSA, FACP
  Peer
15
CME/CE
0.25 credits
Combating CMV in HCT Recipients: A New Era of Therapy
0.25 credits

CME/CE

- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
3
CME/CE
0.50 credits
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Tr...
0.50 credits
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
- Kai He, MD, PhD
  Peer
- Jyoti D. Patel, MD, FASCO
  Peer
4
CME/CE
0.25 credits
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Globa...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
4
CME/CE
0.25 credits
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lu...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
4
CME/CE
0.25 credits
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits

Clinical Practice

- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
5
CME/CE
0.50 credits
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and T...
0.50 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
3
CME/CE
0.25 credits
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Ca...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Suresh S. Ramalingam, MD
  Peer
6
CME/CE
0.25 credits
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
0.25 credits
- Jyoti D. Patel, MD, FASCO
  Peer
- Kai He, MD, PhD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
3
CME/CE
0.25 credits
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Globa...
0.25 credits

Programs

- William D. Tap, MD
  Peer
- John Healey, MD
  Peer
6
CME/CE
0.25 credits
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
0.25 credits
- Ana Ferreira Castro, MD
  Peer
- Gilberto de Castro Junior, MD, PhD
  Peer
- Ricard Mesia, MD, PhD
  Peer
- Zujun Li, MD
  Peer
0
CME/CE
0.25 credits
Actualización sobre inmunoterapia: tratamiento de carcinoma recurrente o meta...
0.25 credits
- Warner K. Huh, MD
  Peer
- Deborah K. Armstrong, MD
  Peer
- Robert L. Coleman, MD, FACOG, FACS
  Peer
11
CME/CE
0.25 credits
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
0.25 credits
- Javier Cortes, MD, PhD
  Peer
- Giuseppe Curigliano, MD, PhD
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
3
CME/CE
0.25 credits
Aplicación de evidencias del mundo real para mejorar la toma de decisiones cl...
0.25 credits